Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Predictors and patterns of weight gain during treatment for tuberculosis in the United States of America.

Phan MN, Guy ES, Nickson RN, Kao CC.

Int J Infect Dis. 2016 Dec;53:1-5. doi: 10.1016/j.ijid.2016.09.006. Epub 2016 Sep 28.

2.

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.

3.

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.

Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW; Tuberculosis Trials Consortium.

J Infect Dis. 2012 Oct 1;206(7):1030-40. Epub 2012 Jul 30.

PMID:
22850121
4.

Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.

Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE; Tuberculosis Clinical Trials Consortium.

Int J Tuberc Lung Dis. 2012 Apr;16(4):473-9. doi: 10.5588/ijtld.11.0548.

PMID:
22325844
5.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team.

N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.

6.

Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; Tuberculosis Trials Consortium.

PLoS One. 2010 May 20;5(5):e10753. doi: 10.1371/journal.pone.0010753.

7.

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium.

Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30.

PMID:
19406981
8.

Ground water geochemistry of Ballia district, Uttar Pradesh, India and mechanism of arsenic release.

Chauhan VS, Nickson RT, Chauhan D, Iyengar L, Sankararamakrishnan N.

Chemosphere. 2009 Mar;75(1):83-91. doi: 10.1016/j.chemosphere.2008.11.065. Epub 2009 Jan 8.

PMID:
19135229
9.

Evaluation of two commercial field test kits used for screening of groundwater for arsenic in Northern India.

Sankararamakrishnan N, Chauhan D, Nickson RT, Tripathi RM, Iyengar L.

Sci Total Environ. 2008 Aug 15;401(1-3):162-7. doi: 10.1016/j.scitotenv.2008.03.042. Epub 2008 Jun 2.

PMID:
18514262
10.

Current knowledge on the distribution of arsenic in groundwater in five states of India.

Nickson R, Sengupta C, Mitra P, Dave SN, Banerjee AK, Bhattacharya A, Basu S, Kakoti N, Moorthy NS, Wasuja M, Kumar M, Mishra DS, Ghosh A, Vaish DP, Srivastava AK, Tripathi RM, Singh SN, Prasad R, Bhattacharya S, Deverill P.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2007 Oct;42(12):1707-18.

PMID:
17952772
11.

Proton Irradiation Facility and space radiation monitoring at the Paul Scherrer Institute.

Hajdas W, Zehnder A, Adams L, Buehler P, Harboe-Sorensen R, Daum M, Nickson R, Daly E, Nieminen P.

Phys Med. 2001;17 Suppl 1:119-23.

PMID:
11770526
12.

The fate of diphenyl sulphide, diphenyl sulphoxide and diphenyl sulphone in the rat.

Mitchell SC, Nickson RM, Porter ER, Jackson WF, Preston SL, Zhang AQ.

Drug Metabol Drug Interact. 2000;16(3):191-206.

PMID:
11116753
13.

Arsenic poisoning of Bangladesh groundwater.

Nickson R, McArthur J, Burgess W, Ahmed KM, Ravenscroft P, Rahman M.

Nature. 1998 Sep 24;395(6700):338. No abstract available.

PMID:
9759723
14.

RĂ´le of bile in the elimination of dipropyl sulphone from the male rat.

Nickson RM, Mitchell SC.

Drug Metabol Drug Interact. 1996;13(2):145-53.

PMID:
8905246
15.

Fate of dipropyl sulphone in rat.

Nickson RM, Mitchell SC, Zhang AQ.

Xenobiotica. 1995 Dec;25(12):1391-8.

PMID:
8719913
16.

Distribution of dipropyl [35S]-sulphoxide in the rat.

Nickson RM, Mitchell SC.

Drug Metabol Drug Interact. 1995;12(1):65-75.

PMID:
7555003
17.

Fate of dipropyl sulphide and dipropyl sulphoxide in rat.

Nickson RM, Mitchell SC.

Xenobiotica. 1994 Feb;24(2):157-68.

PMID:
8017090
18.

Toxicity of dipropyl sulphoxide.

Nickson RM, Mitchell SC.

Biochem Soc Trans. 1992 May;20(2):211S. No abstract available.

PMID:
1397586
19.

Management development. Dawn of the age of accountability.

Nickson R.

Health Soc Serv J. 1985 Jan 10;95(4930):41-3. No abstract available.

PMID:
10270974

Supplemental Content

Loading ...
Support Center